MedPath

Balaglitazone

Generic Name
Balaglitazone
Drug Type
Small Molecule
Chemical Formula
C20H17N3O4S
CAS Number
199113-98-9
Unique Ingredient Identifier
4M1609828O

Overview

Balaglitazone has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Background

Balaglitazone has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath